All Posts

Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test

Todos Medical, a comprehensive medical diagnostics and related solutions company, today announced that it has acquired Provista Diagnostics, Inc. Provista is a medical diagnostics company based in Alpharetta, Georgia that owns the intellectual property rights to the proprietary breast cancer blood test, Videssa, and has a diagnostic testing laboratory currently performing COVID-19 PCR testing, primarily for the medical and entertainment industries. The…

Period Apparel Company Ruby Love Secures a New Round of Investment Led by SteelSky Ventures

New York-based period apparel company Ruby Love has recently closed a round of funding led by the women’s health fund SteelSky Ventures. Base10 also participated in the financing. The company had previously secured a $15 million Series A deal and has now added additional funding to grow its line of period underwear, swimsuits, loungewear, and active gear. The line of sustainable period wear expands the menstrual…

Unilever Ventures-Backed Womaness Launches a Collection of New Menopause Products

Unilever Ventures-backed Womaness launches a collection of modern, effective menopause products created by women, for women that offer solutions from head to toe and everything in between. The Womaness line includes 13 products, all under $40, across the skin and body care, feminine care/sexual health, and supplement categories and is available at womaness.com as well as at a nationwide retailer. Womaness was born…

What’s New in Femtech This Week? (April 22, 2020)

Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your…

New Community-Driven Campaign Addresses the “Women’s Health? That’s So Niche” Prejudice

A new campaign spearheaded by Rosy founder & CEO Dr. Lyndsey Harper launches today with the goal to address the false notion that women’s health is niche, a prejudice many femtech founders are faced with when raising capital these days. But don’t just take our word for it! The data speaks for itself and paints a clear picture on why women’s health…

Willow Adds $26.8M in an Extended Series C Round to Invest in Product Development and Further Expansion

Willow, the company forever changing the way moms pump with the world’s first all-in-one, in-bra wearable breast pump with full spill-proof mobility, today announced an additional $26.8 Million in funding through a Series C Extension round –  led by Endeavour Vision, alongside NEA (New Enterprise Associates), Pura Vida Investments, Purple Arch Ventures (a part of Alumni Ventures Group), Logos Capital, and Gaingels. This extension…

Women’s Health Biotech Daré Bioscience Appoints Dr. Sophia N. Ononye-Onyia to its Board of Directors

Daré Bioscience, a leader in women’s health innovation, today announced the appointment of Sophia N. Ononye-Onyia, PhD MPH MBA to its Board of Directors. Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve…

UroMems Raises a $23M Series B to Fund Final Development of its Implantable Medical Device for Those Suffering from Urinary Incontinence

UroMems, developer and manufacturer of the electronic artificial urinary sphincter (eAUS), today announced that it has raised an additional €7 million in a second tranche of its previously announced Series B financing round completed in May 2020. The additional capital was provided by existing investors including Hil-Invent GmbH, Financière Arbevel, Wellington Partners, Bpifrance, via its FABS fund, Supernova Invest and btov Partners,…